Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways
Hongxuan Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Aibing Wang(Hunan Agricultural University), Gregory M. Williams(Johns Hopkins University), De‐Pei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yue Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Y LIU(Chinese Academy of Medical Sciences & Peking Union Medical College), Guangyan Liu(Sun Yat-sen University), Dan Hao(Beijing National Laboratory for Molecular Sciences)
Cited by 106
Related Papers
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|Nature Medicine|2005|3.7k
Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice
|Cardiovascular Research|2008|388
SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy
|Circulation|2017|353
Mitochondria, endothelial cell function, and vascular diseases
|Frontiers in Physiology|2014|352
Repression of P66Shc Expression by SIRT1 Contributes to the Prevention of Hyperglycemia-Induced Endothelial Dysfunction
|Circulation Research|2011|274